company background image
4581 logo

Taisho Pharmaceutical Holdings TSE:4581 Stock Report

Last Price

JP¥8.58k

Market Cap

JP¥703.3b

7D

-0.1%

1Y

50.0%

Updated

12 Apr, 2024

Data

Company Financials +

Taisho Pharmaceutical Holdings Co., Ltd.

TSE:4581 Stock Report

Market Cap: JP¥703.3b

4581 Stock Overview

Through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally.

4581 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Taisho Pharmaceutical Holdings Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Taisho Pharmaceutical Holdings
Historical stock prices
Current Share PriceJP¥8,580.00
52 Week HighJP¥8,753.00
52 Week LowJP¥5,150.00
Beta0.50
11 Month Change-0.035%
3 Month Change-0.44%
1 Year Change50.00%
33 Year Change28.06%
5 Year Change-14.11%
Change since IPO27.11%

Recent News & Updates

Recent updates

Shareholder Returns

4581JP PharmaceuticalsJP Market
7D-0.1%3.6%1.2%
1Y50.0%23.7%27.4%

Return vs Industry: 4581 exceeded the JP Pharmaceuticals industry which returned 6.3% over the past year.

Return vs Market: 4581 exceeded the JP Market which returned 33.8% over the past year.

Price Volatility

Is 4581's price volatile compared to industry and market?
4581 volatility
4581 Average Weekly Movement0.3%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement3.8%
10% most volatile stocks in JP Market7.3%
10% least volatile stocks in JP Market1.9%

Stable Share Price: 4581 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4581's weekly volatility (0%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19128,784Akira Ueharawww.taisho-holdings.co.jp

Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) drugs and prescription pharmaceutical products in Japan and internationally. It operates through Self-Medication Operation Group and Prescription Pharmaceutical Operation Group segments. The company offers OTC drugs, quasi-drugs, food products, and general medical and hygiene supplies, such as Lipovitan series of energy drinks; the Pabron series of cold remedies and sinus treatments; the RiUP series of hair re-growth treatment products; the Taisho Kampo series of gastrointestinal treatment products; the Colac series of laxative products; the Naron series and other products for antipyretic analgesics; the Preser series of hemorrhoid treatment products; Hapacol, Efferalgan, Dafalgan, and Tempra for antipyretic analgesics; Counterpain topical anti-inflammatory analgesics; Vitacilina, a dermatological treatment product; and VICKS, a cough suppressant throat lozenges and medicated drops.

Taisho Pharmaceutical Holdings Co., Ltd. Fundamentals Summary

How do Taisho Pharmaceutical Holdings's earnings and revenue compare to its market cap?
4581 fundamental statistics
Market capJP¥703.28b
Earnings (TTM)JP¥8.42b
Revenue (TTM)JP¥320.39b

83.5x

P/E Ratio

2.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4581 income statement (TTM)
RevenueJP¥320.39b
Cost of RevenueJP¥137.22b
Gross ProfitJP¥183.17b
Other ExpensesJP¥174.74b
EarningsJP¥8.42b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)102.74
Gross Margin57.17%
Net Profit Margin2.63%
Debt/Equity Ratio0%

How did 4581 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

97%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.